Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hikal Limited ( (IN:HIKAL) ) just unveiled an update.
Hikal Limited has announced the closure of its trading window for designated persons and their immediate relatives starting April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct. The window will remain shut until 48 hours after the declaration of the company’s financial results for the quarter and year ended March 31, 2026, underscoring its compliance focus and aiming to prevent any potential misuse of unpublished price-sensitive information ahead of earnings disclosure.
More about Hikal Limited
Hikal Limited is an India-based company operating in the chemicals and pharmaceuticals space, with administrative offices in Navi Mumbai and a registered office in Mumbai. The company is listed on both BSE and NSE under the scrip code 524735 and symbol HIKAL, respectively, and is subject to Securities and Exchange Board of India regulations on insider trading and corporate governance.
Average Trading Volume: 60,974
Technical Sentiment Signal: Sell
Current Market Cap: 19.33B INR
Find detailed analytics on HIKAL stock on TipRanks’ Stock Analysis page.